Shares of Sanofi (EPA: SAN) jumped 1% after the French drugmaker said its income rose 5.6% in the second quarter. As a result, the firm has raised its full-year earnings forecast to 6-7%, higher than 5% previously expected.
The world’s fifth-largest pharma company saw its net income rise by 5.6% to 1.6 billion euros. Sanofi implemented a series of cost-cutting measures which saved nearly 1 billion. In June, Sanofi cut 1,680 jobs to slash costs and boost profits.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The French giant also said it made $11.7 billion from selling shares in Regeneron two months ago. However, revenue fell 3.4% to 8.2 billion euros on the back of a weaker-than-expected performance of its vaccine and consumer healthcare businesses.
“I’m proud of what the team delivered in the second quarter. Even with some headwinds from the COVID-19 pandemic, we achieved business EPS growth,” said Sanofi’s Chief Executive Officer Paul Hudson.
The UK government said today it agreed to buy 60 million doses of potential COVID-19 vaccine from Sanofi and GlaxoSmithKline in a deal worth £500 million.
“With our partner GSK, we are pleased to co-operate with the UK government as well as several other countries and global organisations as part of our ongoing efforts to develop a safe and effective vaccine and make it available as quickly as possible,” commented Thomas Triomphe, executive vice-president and global head of Sanofi Pasteur.
Sanofi share price is trading around the 90.00 mark. Last week, the share price surged to print a 5-year high.
